Cart
sales@molnova.com
1-methoxycyclopropanecarboxylic acid
CAS No. 100683-08-7
1-methoxycyclopropanecarboxylic acid( —— )
Catalog No. M28687 CAS No. 100683-08-7
1-methoxycyclopropanecarboxylic acid is an agonist of free fatty acid receptor 3 (FFAR3, human).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 29 | Get Quote |
|
| 5MG | 45 | Get Quote |
|
| 10MG | 68 | Get Quote |
|
| 25MG | 115 | Get Quote |
|
| 50MG | 173 | Get Quote |
|
| 100MG | 258 | Get Quote |
|
| 200MG | 388 | Get Quote |
|
| 500MG | 642 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product Name1-methoxycyclopropanecarboxylic acid
-
NoteResearch use only, not for human use.
-
Brief Description1-methoxycyclopropanecarboxylic acid is an agonist of free fatty acid receptor 3 (FFAR3, human).
-
Description1-methoxycyclopropanecarboxylic acid is an agonist of free fatty acid receptor 3 (FFAR3, human).
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayCell Cycle/DNA Damage
-
TargetGPR
-
RecptorAntifungal
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number100683-08-7
-
Formula Weight116.116
-
Molecular FormulaC5H8O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCOC1(CC1)C(O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Wang, S.Y., Sun, T., and Faust, M.Translocation of paclobutrazol, a gibberellin biosynthesis inhibitor, in apple seedlingsPlant Physiology82(1)11-14(1986)
molnova catalog
related products
-
SB271046
SB271046 is a potent, selective and orally active 5-HT6 receptor antagonist with pKi of 8.9, exhibits 200-fold greater selectivity over other 5-HT receptor subtypes.
-
Questiomycin A
Questiomycin A is an antibiotic produced in crème fraiche with antibacterial and anticancer activities. Questiomycin A suppresses expression of GRP78, a cell-protective ER chaperone protein.
-
Latanoprost acid
Latanoprost acid is a selective agonist of prostanoid receptors and inhibits RANKL-induced osteoclastogenesis and function through the inhibition of c-fos/NFATc1 pathway.
